These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15494454)

  • 1. Mutually exclusive recombination of wild-type and mutant loxP sites in vivo facilitates transposon-mediated deletions from both ends of genomic DNA in PACs.
    Chatterjee PK; Shakes LA; Srivastava DK; Garland DM; Harewood KR; Moore KJ; Coren JS
    Nucleic Acids Res; 2004; 32(18):5668-76. PubMed ID: 15494454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal cross-recombination between wild-type and loxP511 sites in vivo facilitates truncating both ends of large DNA inserts in pBACe3.6 and related vectors.
    Shakes LA; Garland DM; Srivastava DK; Harewood KR; Chatterjee PK
    Nucleic Acids Res; 2005 Aug; 33(13):e118. PubMed ID: 16061933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolating large nested deletions in bacterial and P1 artificial chromosomes by in vivo P1 packaging of products of Cre-catalysed recombination between the endogenous and a transposed loxP site.
    Chatterjee PK; Coren JS
    Nucleic Acids Res; 1997 Jun; 25(11):2205-12. PubMed ID: 9153322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selecting transpositions using phage P1 headful packaging: new markerless transposons for functionally mapping long-range regulatory sequences in bacterial artificial chromosomes and P1-derived artificial chromosomes.
    Chatterjee PK; Mukherjee S; Shakes LA; Wilson W; Coren JS; Harewood KR; Byrd G
    Anal Biochem; 2004 Dec; 335(2):305-15. PubMed ID: 15556570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directing enhancer-traps and iTol2 end-sequences to deleted BAC ends with loxP- and lox511-Tn10 transposons.
    Chatterjee PK
    Methods Mol Biol; 2015; 1227():99-122. PubMed ID: 25239743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput screen identifying sequence and promiscuity characteristics of the loxP spacer region in Cre-mediated recombination.
    Missirlis PI; Smailus DE; Holt RA
    BMC Genomics; 2006 Apr; 7():73. PubMed ID: 16595017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered directionality in the Cre-LoxP site-specific recombination pathway.
    Aranda M; Kanellopoulou C; Christ N; Peitz M; Rajewsky K; Dröge P
    J Mol Biol; 2001 Aug; 311(3):453-9. PubMed ID: 11492999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of loxP sites for efficient Cre-mediated insertion into genomic DNA.
    Thomson JG; Rucker EB; Piedrahita JA
    Genesis; 2003 Jul; 36(3):162-7. PubMed ID: 12872248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimization of the Escherichia coli genome using a Tn5-targeted Cre/loxP excision system.
    Yu BJ; Sung BH; Koob MD; Lee CH; Lee JH; Lee WS; Kim MS; Kim SC
    Nat Biotechnol; 2002 Oct; 20(10):1018-23. PubMed ID: 12244329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimization of the Escherichia coli genome using the Tn5-targeted Cre/loxP excision system.
    Yu BJ; Kim C
    Methods Mol Biol; 2008; 416():261-77. PubMed ID: 18392973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting and retrofitting pre-existing libraries of transposon insertions with FRT and oriV elements for in-vivo generation of large quantities of any genomic fragment.
    Wild J; Sektas M; Hradecná Z; Szybalski W
    Gene; 1998 Nov; 223(1-2):55-66. PubMed ID: 9858684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific and directional gene replacement mediated by Cre recombinase.
    Trinh KR; Morrison SL
    J Immunol Methods; 2000 Oct; 244(1-2):185-93. PubMed ID: 11033031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited use of the Cre/loxP recombination system in efficient production of loxP-containing minicircles in vivo.
    Sektas M; Specht M
    Plasmid; 2005 Mar; 53(2):148-63. PubMed ID: 15737402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using an in vivo phagemid system to identify non-compatible loxP sequences.
    Siegel RW; Jain R; Bradbury A
    FEBS Lett; 2001 Sep; 505(3):467-73. PubMed ID: 11576551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using an in vivo phagemid system to identify non-compatible loxP sequences.
    Siegel RW; Jain R; Bradbury A
    FEBS Lett; 2001 Jun; 499(1-2):147-53. PubMed ID: 11418130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PepA and ArgR do not regulate Cre recombination at the bacteriophage P1 loxP site.
    MacDonald AI; Lu Y; Kilbride EA; Akopian A; Colloms SD
    Plasmid; 2008 Mar; 59(2):119-26. PubMed ID: 18226834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new site-specific recombinase-mediated system for targeted multiple genomic deletions employing chimeric loxP and mrpS sites.
    Warth L; Altenbuchner J
    Appl Microbiol Biotechnol; 2013 Aug; 97(15):6845-56. PubMed ID: 23536006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination.
    Lee G; Saito I
    Gene; 1998 Aug; 216(1):55-65. PubMed ID: 9714735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic targeting of a bicistronic DNA fragment by Cre-mediated site-specific recombination.
    Kolb AF; Siddell SG
    Gene; 1997 Dec; 203(2):209-16. PubMed ID: 9426252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant loxP vectors for selectable marker recycle and conditional knock-outs.
    Arakawa H; Lodygin D; Buerstedde JM
    BMC Biotechnol; 2001; 1():7. PubMed ID: 11591226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.